(Q39949505)
Statements
A Randomized Trial to Assess the Efficacy and Safety of ABT-126, a Selective α7 Nicotinic Acetylcholine Receptor Agonist, in the Treatment of Cognitive Impairment in Schizophrenia (English)
George M Haig
Earle E Bain
Weining Z Robieson